Efficacy, safety, and prognostic factors of capecitabine plus temozolomide regimen in patients with atypical thymic carcinoids

MLA

Man Liu, et al. “Efficacy, Safety, and Prognostic Factors of Capecitabine plus Temozolomide Regimen in Patients with Atypical Thymic Carcinoids.” Therapeutic Advances in Medical Oncology, vol. 16, Nov. 2024. EBSCOhost, https://doi.org/10.1177/17588359241297578.

APA

Man Liu, Xu Yan, Xiaoxuan Lin, Luohai Chen, Yu Wang, Yanji Luo, Yuan Lin, Qiao He, Jie Chen, & Ning Zhang. (2024). Efficacy, safety, and prognostic factors of capecitabine plus temozolomide regimen in patients with atypical thymic carcinoids. Therapeutic Advances in Medical Oncology, 16. https://doi.org/10.1177/17588359241297578

Chicago

Man Liu, Xu Yan, Xiaoxuan Lin, Luohai Chen, Yu Wang, Yanji Luo, Yuan Lin, Qiao He, Jie Chen, and Ning Zhang. 2024. “Efficacy, Safety, and Prognostic Factors of Capecitabine plus Temozolomide Regimen in Patients with Atypical Thymic Carcinoids.” Therapeutic Advances in Medical Oncology 16 (November). doi:10.1177/17588359241297578.